Pharmacogenomics logo Future Medicine logo

Pharmacogenomics provides the community with an essential resource for keeping abreast of the latest developments in new pharmacogenomic initiatives, emerging technologies for accessing genomic information and the development of novel diagnostic products and strategies.

Publisher: Future Medicine

More about this publication?
Related content
Volume 10, Number 5, May 2009

< previous issue | all issues | next issue >

Editorial

MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion
pp. 711-713(3)
Authors: Lööscher, Wolfgang; Delanty, Norman

News & Views

Research Highlights

Research Highlights
pp. 719-722(4)
Authors: Huang, R Stephanie; Mi, Shuangli

Research Article

Gene-wide tagging study of association between ABCB1 polymorphisms and multidrug resistance in epilepsy in Han Chinese
pp. 723-732(10)
Authors: Kwan, Patrick; Wong, Virginia; Ng, Ping Wing; Lui, Colin Hiu Tung; Sin, Ngai Chuen; Poon, Wai Sang; Ng, Ho Keung; Wong, Ka Sing; Baum, Larry

UGT1A1*28 genotype predicts gastrointestinal toxicity in patients treated with intermediate-dose irinotecan
pp. 733-739(7)
Authors: Ferraldeschi, Roberta; Minchell, Laura J; Roberts, Stephen A; Tobi, Simon; Hadfield, Kristen D; Blackhall, Fiona H; Mullamitha, Saifee; Wilson, Gregory; Valle, Juan; Saunders, Mark; Newman, William G

Systematic screening for polymorphisms within the UGT1A6 gene in three Chinese populations and function prediction through structural modeling
pp. 741-752(12)
Authors: Xing, Yi; Yang, Lun; Wang, Lei; Shao, Liyan; Wei, Zhiyun; Xuan, Jiekun; Li, Jun; Qin, Shengying; Shu, Anli; He, Lin; Xing, Qinghe

Asthma pharmacogenetic study using finite mixture models to handle drug-response heterogeneity
pp. 753-767(15)
Authors: York, Timothy P; Vargas-Irwin, Cristina; Anderson, Wayne H; van den Oord, Edwin JCG

Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population
pp. 769-778(10)
Authors: Gunes, Arzu; Ozbey, Gul; Vural, Elif Hilal; Uluoglu, Canan; Scordo, Maria Gabriella; Zengil, Hakan; Dahl, Marja-Liisa

Review

Immunogenetics of drug-induced skin blistering disorders. Part II: Synthesis
pp. 779-816(38)
Authors: Bowman, Clive; Delrieu, Olivier

Epilepsy pharmacogenetics
pp. 817-836(20)
Authors: Kasperaviččiūūtėė, Dalia; Sisodiya, Sanjay M

Application of pharmacogenomics to vaccines
pp. 837-852(16)
Authors: Poland, Gregory A; Ovsyannikova, Inna G; Jacobson, Robert M

Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: a systematic review
pp. 853-866(14)
Authors: van der Zwaluw, Carmen S; Engels, Rutger CME; Buitelaar, Jan; Verkes, Robbert J; Franke, Barbara; Scholte, Ron HJ

Histamine pharmacogenomics
pp. 867-883(17)
Authors: Garcíía-Martíín, Elena; Ayuso, Pedro; Martíínez, Carmen; Blanca, Miguel; Agúúndez, Joséé AG

Special Report

United Europeans for development of pharmacogenomics in multiple sclerosis network
pp. 885-894(10)
Authors: Vandenbroeck, Koen; Comabella, Manuel; Tolosa, Eva; Goertsches, Robert; Brassat, David; Hintzen, Rogier; Infante-Duarte, Carmen; Favorov, Alexander; Escorza, Sergio; Palacios, Ricardo; Oksenberg, Jorge R; Villoslada, Pablo

Technology Report

Acknowledgements

Acknowledgements
pp. 925-925(1)

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page